Skip to content
Search

Latest Stories

CCA calls government to commission pharmacies as first port of call for cardiovascular care

Community pharmacies will be able to deliver approximately 15 million blood pressure screenings by 2026, revealed the Company Chemists’ Association (CCA)'s new research.

This will also prevent 15,000 people from suffering heart attacks or strokes. CCA has called the Government to take up their offer and commission pharmacies as the first port of call for cardiovascular care.


“Thousands of lives can be saved with ambitious commissioning and the investment to match,” said CCA.

There is an opportunity to use the expertise of community pharmacy to go further and provide the care these newly identified patients’ need. To do this the sector needs funding and workforce.

The association said: “Community pharmacy is under great financial pressure, suffering a real term funding cut of over 30% over 8 years. With funding, the sector can transform to deliver this critical need for patients.

Whilst there are plans to train Independent Prescribers (IPs), there are no clear roles for them to use these skills. There is a need to accelerate training plans to allow pharmacists to deliver the service described here and play their part in CVD management.”

Malcolm Harrison, Chief Executive of the CCA said: “Pharmacies will deliver 15 million blood pressure checks by 2026.  The sector can, and should, play a huge role in the nations fight against cardiovascular disease.

Whilst the funding model for community pharmacy is broken, it is not beyond repair. Investing in community pharmacy to become the first point of contact for cardiovascular disease is a sure-fire way of freeing up GP capacity, reversing health inequalities and ultimately saving lives.

On average pharmacies are underfunded by more than £67,000 every year. It’s now time that the Government and NHS invest in the tremendous potential of community pharmacy”.

John Maingay, Director of Policy and Influencing at the British Heart Foundation, said: “By delivering blood pressure checks to more people more easily, high street pharmacies are helping to save lives every day. Local pharmacies are well placed to detect high blood pressure and help people receive appropriate care, while also relieving some of the immense pressure on GPs.

“High blood pressure often doesn’t present any symptoms but if left untreated, it can lead to a life-threatening heart attack or stroke. That’s why it’s important to get your blood pressure checked at a local pharmacy, GP surgery or during a free NHS health check in England, especially if you have a family history of heart and circulatory diseases. A quick and simple five-minute test could prevent a future heart attack or stroke, and even save your life.”

Since October 2021, community pharmacies in England have been commissioned to screen people for high blood pressure – a key risk factor for heart attacks and strokes.

After the first year of the service, community pharmacies delivered nearly 600,000 blood pressure checks identifying over 25,000 people with high blood pressure. 44% of these checks were in the 30% most deprived communities. Using modelling from UCL, we calculate this has prevented over 600 heart attacks and strokes already.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less